- Report
- December 2022
- 100 Pages
Global
From €5335EUR$5,950USD£4,568GBP
- Report
- September 2025
- 110 Pages
Middle East
From €5335EUR$5,950USD£4,568GBP
- Report
- December 2024
- 150 Pages
Global
From €5335EUR$5,950USD£4,568GBP
- Report
- May 2024
- 183 Pages
Global
From €2242EUR$2,500USD£1,919GBP
- Report
- October 2023
- 117 Pages
Global
From €4035EUR$4,500USD£3,455GBP
- Report
- August 2025
- 183 Pages
Global
From €3179EUR$3,545USD£2,722GBP
€3532EUR$3,939USD£3,024GBP
- Report
- August 2025
- 182 Pages
Global
From €3179EUR$3,545USD£2,722GBP
€3532EUR$3,939USD£3,024GBP
- Report
- August 2025
- 181 Pages
Global
From €3179EUR$3,545USD£2,722GBP
€3532EUR$3,939USD£3,024GBP
- Report
- August 2025
- 180 Pages
Global
From €3179EUR$3,545USD£2,722GBP
€3532EUR$3,939USD£3,024GBP
- Report
- August 2025
- 188 Pages
Global
From €3179EUR$3,545USD£2,722GBP
€3532EUR$3,939USD£3,024GBP
- Report
- August 2025
- 196 Pages
Global
From €3179EUR$3,545USD£2,722GBP
€3532EUR$3,939USD£3,024GBP
- Report
- August 2025
- 186 Pages
Global
From €3179EUR$3,545USD£2,722GBP
€3532EUR$3,939USD£3,024GBP
- Report
- November 2024
- 323 Pages
Global
From €4484EUR$5,000USD£3,839GBP
From €3138EUR$3,500USD£2,687GBP
- Report
- April 2025
- 70 Pages
Saudi Arabia
From €3138EUR$3,500USD£2,687GBP
- Report
- August 2024
- 85 Pages
India
From €3138EUR$3,500USD£2,687GBP
- Report
- May 2024
- 85 Pages
Vietnam
From €3138EUR$3,500USD£2,687GBP
- Report
- August 2023
- 76 Pages
France
From €3138EUR$3,500USD£2,687GBP
- Report
- June 2023
- 73 Pages
United Kingdom
From €3138EUR$3,500USD£2,687GBP
- Report
- August 2025
- 192 Pages
Global
From €3179EUR$3,545USD£2,722GBP
€3532EUR$3,939USD£3,024GBP

A xenograft is a type of biotechnology that involves the transplantation of tissue from one species to another. It is commonly used in medical research and in the development of new treatments for diseases. Xenografts are also used in the production of therapeutic proteins, such as antibodies, and in the production of cell-based therapies.
The xenograft market is a rapidly growing sector of the biotechnology industry. It is driven by the increasing demand for new treatments for diseases, as well as the need for more efficient and cost-effective production of therapeutic proteins and cell-based therapies. The market is also driven by advances in technology, such as gene editing and stem cell research, which have enabled the development of more sophisticated xenografts.
Some of the major companies in the xenograft market include Novartis, Pfizer, Merck, and Amgen. These companies are involved in the development and production of xenografts for medical research and therapeutic applications. Other companies in the market include AbbVie, AstraZeneca, and Regeneron. Show Less Read more